Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Long-term Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions-LEA

NCT03017014 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT03017014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03017014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Long-term Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions-LEA
Lead sponsor
AbbVie
Phase
Observational
Overall status
Terminated
Start date
September 26, 2017
Completion date
October 14, 2019
Enrollment
62 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease